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rectly stimulate production of a helper T-cell type 1 
response that has been shown to be involved in ef-
fectively clearing Leishmania in the skin lesions.
Conclusion: Fluconazole 400 mg/day during 6 
weeks appears to be a safe and effective treatment 
of leishmaniasis caused by L. major for patients who 
cannot be managed by local treatment only. Asso-
ciation with other treatments like 5% imiquimod 
cream or cryotherapy may accelerate healing of the 
lesions.
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A pollutant waste incinerator was exploited in Me-
lun area in south of Paris for 28 years. Dioxin analysis 
of the fumes released by the incinerator, the soil, the 
eggs and the blood of several inhabitants indicated 
that this population had been exposed to dioxin-
like compounds over a long period of time.
Here we describe the morphological analysis of 43 
cases (23 m, 20 f ) from this population. Hematox-
ylin-Eosin-stained sections from retroauricular and 
lesional skin biopsies were analysed.
On histological examination, diagnosis of normal 
skin was made for 6 of these patients. 22 patients 
showed histologically perifolliculitis, with a nonspe-
cific dermal inflammatory infiltrate in two patients, 
follicular eczema in one patient and eosinophilic 
infiltrate in one patient. Inflammatory infiltrate was 
composed of lymphocytes, sometimes in addition 
with some neutrophils or eosinophils. Follicular wall 
was not destructed in any of these cases. On histo-
logical examinati on, 4 of the 43 patients showed 
cystic lesions compatible with chloracne/MADISH, 
three of them were also detected clinically.
The impact on health on long-term exposure to 
subtoxic doses of dioxin-like compounds is un-
known. Here we show in a population exposed for 
a long time to low amounts of dioxin from the en-
vironment some cutaneous morphological changes 
compatible with those observed in acute dioxin in-
toxication. By completing this analysis with immu-
nohistochemical labelling such as CYP1A1, it would 
be possible to use the morphological analysis of 
skin biopsies as a biomarker of chronic exposure to 
low dose of dioxin-like pollutants
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Background: We describe the case of a 25 year-old 
male patient who presented with a papule situated 
on his forearm. The lesion was red-brown colored 
and hard on palpation.  The clinical differential dif-
ferential diagnosis was cystic lesion versus a benign 
adnexal tumor.
Methods: Histological slides of paraffin-embedded 
biopsy material from the patient mentioned above 
have been analyzed on Hematoxylin-Eosin-stained 
sections and on immunohistochemical stains for 
Melan-A, HMB-45, Factor XIII, desmin, CD68, CD31, 
CD34, alpha-actin and S-100.
Results: Histological examination showed a slightly 
hyperplastic epidermis overlying a well-demar-
cated dermal proliferation of non-atypical small, 
sometimes spindle-shaped or epithelioid cells, 
sometimes regrouped around small vessels. Im-
munohistochemistry showed that these cells were 
positive for Melan-A, HMB-45 and Factor XIII, and 
negative for desmin, CD68 and S-100. CD31, CD34 
and alpha-ac tin marked vessel walls, without any 
reaction in the tumor cells.
Conclusion: This histopathological and immunohis-
tochemical phenotype is suggestive for a perivascu-
lar epithelioid cell tumor (PEComa). PEComa is a rare 
mesenchymal tumor recently described, composed 
of cells which express normally melanocyte and 
smooth muscle markers. It seems to have a benign 
behavior, but follow-up data are limited. PEComa 
mainly affects the abdominopelvic region. Angio-
myolipoma of the kidney and liver, sugar tumor 
of the lung, lymphangiomatosis and lymphangio-
myoma are part of the large spectrum of PEComas. 
In the skin, PEComas are extremely rare and often 
misdiagnosed.
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A 38-year-old female patient presented with recal-
citrant acne. The lesions, which had first appeared 
in adolescence, appear in the face and on the trunk. 
The patient describes numerous inflammatory 
partly crusted nodules, which sometimes heal with 
relevant scarring. They did not respond to topical 
anti-inflammatory treatments and also two courses 
of systemic retinoids with cumulative doses of 150 
mg / kg failed. Interestingly, the patient reports 
complete remission of the skin lesions during her 
two pregnancies. There were no concomitant other 
diseases, no drug-intake and family history for skin 
diseases, mainly acne was negative.
Clinical examination revealed sharply demarcated, 
tender inflammatory nodules of up to 4-5 mm diam-
eter on the trunk, focal scarring in the face, but no 
comedones. From a skin swab taken from beneath P
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a crust was grown staphylococcus aureus. The nitro-
blue tetrazolium test (NBT) performed because her 
son was suffering from recurrent infect ions showed 
reduced phagocyte NADPH oxidase activity. Genet-
ic tests finally confimed X-linked chronic granulo-
matous disease (CGD).
CGD is a genetically heterogeneous condition char-
acterized by recurrent life-threatening bacterial and 
fungal infections and granuloma formation. CGD is 
caused by defects in the phagocyte NADPH oxidase, 
which result in the inability of phagocytes (neutro-
phils, monocytes, and macrophages) to destroy 
catalase-positive microorganisms. The patients usu-
ally suffer from recurrent infections caused by bac-
terial and fungal pathogens in the skin, lung, lymph 
nodes and liver, and they are prone to the formation 
of granulomata in various organs, growth retarda-
tion and autoimmune disorders. In our patient, re-
current skin infections, which were misdiagnosed 
as recalcitrant acne, were the only symptom. This 
illustrates on one hand the great variability of sever-
ity of CGD and on the other hand that inflammatory 
granulomas in CGD can be misinterpreted as acne.
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Management of prurigo nodularis with the immu-
nosuppressive agent methotrexate: a retrospec-
tive observational study
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Background: Prurigo nodularis (PN) is a chronic, de-
bilitating, inflammatory skin disease. Adherence to 
therapy can be impaired and represents a challenge 
for the physician. Methotrexate (MTX) is a safe folic 
antagonist widely used in the management of in-
flammatory skin diseases such as psoriasis. Weekly 
administration of low-dose methotrexate (L-MTX) 
represents an attractive treatment option and could 
therefore find its place in the management of PN.
Objective: The aim of this retrospective observa-
tional study is to evaluate the efficacy of L-MTX as a 
treatment option for PN.
Methods: We enrolled 14 patients who had failed 
to respond to conventional therapies such as topi-
cal steroids, phototherapy and anti-pruritic agents. 
Subjective symptoms (pruritus score) and objective 
symptoms (Prurigo Nodularis Area and Severity In-
dex score (PN-ASI)) were recorded. Treatment con-
sisted in the subcutaneous administration of 7.5 mg 
to 15 mg/week of MTX for a minimum of 6 m onths. 
The adjuvant application of emollients and topical 
steroids was maintained where needed.
Results: Significant improvement (decrease of pru-
ritus score, PN-ASI>75%) was observed in 11 cases; 
trend to improvement in 1case; no response was 
observed in 1 case; and a relapse was observed in 1 
case after discontinuation of the treatment.
Conclusions: At doses of 7,5 mg to 15 mg/week, 
MTX is a safe treatment and allows improvement or 
healing in some patients, with long lasting remis-
sion.
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Background: Studies evaluating skin irritation have 
traditionally used laboratory animals; however, 
such methods are questionable regarding their rel-
evance for humans. New in vitro methods have re-
cently been developed, such as the reconstructed 
human epidermis (RHE) model. Although the RHE 
method has been validated, the agreement with 
in vivo results such as the 4-hour human patch test 
(HPT) is 76% at best (Epiderm®). There is a need to 
develop an in vitro method that better simulates 
the anatomical and pathological reality encoun-
tered in vivo.
Objectives: Our objective was to develop an in vitro 
method to determine skin irritation from chemical 
exposure using human viable skin, and compare 
our results with already published results.
Methodology: Human skin removed during plastic 
surgery was directly mounted on an in vitro diffu-
sion cell system, and the test chemicals (Heptyl-
butyrate, Hexyl-salicylate, Butyl-Methacrylate, I-Bro-
mohexane) were appli ed on the stratum corneum. 
The skin was exposed for 4 hours. Histopathological 
examinations were used to investigate potential 
skin irritation signs such as spongiosis, necrosis and 
basal vacuolisation.
Results: We obtained 100% agreement with the in 
vivo 4-hour HPT model the classification of irritancy 
for the 5 substances tested; 80% agreement with 
the two RHE models (Episkin® and Epiderm®); and 
60% agreement with the animal model. The coeffi-
cients of variation (CV) between the three different 
test batches were <0.1, showing good reproducibil-
ity in the same laboratory.
Conclusions: This new in vitro test method using 
fresh human skin presented effective results for 
the four tested chemicals. Further investigations 
would be to conduct the same method for a greater 
number of substances; it should also be tested in a 
number of different laboratories in order to suitably 
evaluate its reproducibility.
Key words: skin irritation; fresh human sk in model; 
4-hour human patch test; rabbit test; reconstructed 
human epidermis model.
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